Balyasny Asset Management
EW icon

Balyasny Asset Management’s Edwards Lifesciences EW Stock Holding History

Balyasny Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,600
Closed -$1.67M – 3066
2025
Q4 		$1.67M Sell
19,600
-31,500
-62% -$2.59M ﹤0.01% 1956
2025
Q3 		$3.97M Buy
51,100
+35,600
+230% +$2.78M 0.01% 1479
2025
Q2 		$1.21M Buy
15,500
+8,100
+109% +$604K ﹤0.01% 1971
2025
Q1 		$536K Sell
7,400
-263,600
-97% -$18.9M ﹤0.01% 2249
2024
Q4 		$20.1M Sell
271,000
-391,400
-59% -$27.4M 0.03% 669
2024
Q3 		$43.7M Buy
+662,400
New +$48.1M 0.07% 356
2024
Q2 		– Sell
-10,000
Closed -$956K – 2715
2024
Q1 		$956K Buy
+10,000
New +$840K ﹤0.01% 1812
2023
Q4 		– Sell
-422,500
Closed -$29.3M – 2597
2023
Q3 		$29.3M Buy
+422,500
New +$34M 0.06% 437
2022
Q3 		– Sell
-182,000
Closed -$17.3M – 2950
2022
Q2 		$17.3M Buy
+182,000
New +$18.8M 0.06% 467
2021
Q3 		– Sell
-7,300
Closed -$756K – 2079
2021
Q2 		$756K Buy
+7,300
New +$688K ﹤0.01% 1415
2019
Q4 		– Sell
-90,000
Closed -$6.6M – 1251
2019
Q3 		$6.6M Buy
+90,000
New +$6.32M 0.05% 498
2018
Q4 		– Sell
-342,000
Closed -$17M – 1491
2018
Q3 		$17M Buy
+342,000
New +$16.7M 0.08% 344
2017
Q1 		– Sell
-147,600
Closed -$4.61M – 1638
2016
Q4 		$4.61M Buy
+147,600
New +$4.78M 0.02% 705
2016
Q3 		– Sell
-900,000
Closed -$29.9M – 1073
2016
Q2 		$29.9M Buy
900,000
+480,000
+114% +$16.4M 0.19% 142
2016
Q1 		$12.3M Buy
420,000
+60,000
+17% +$1.66M 0.07% 347
2015
Q4 		$9.48M Sell
360,000
-1,060,200
-75% -$27.5M 0.07% 376
2015
Q3 		$33.7M Buy
+1,420,200
New +$34.3M 0.25% 114

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Balyasny Asset Management's EW Position: Q1 2026 in Review

Balyasny Asset Management reduced its Edwards Lifesciences (EW) stake by 99% in Q1 2026, selling an estimated $129M and leaving 9,998 shares worth $801K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Balyasny Asset Management first reported a position in EW in Q2 2013 and has held it in 33 quarters since. The position peaked at $154M in Q1 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Balyasny Asset Management held 9,998 shares of Edwards Lifesciences worth $801K as of Q1 2026.
  • Balyasny Asset Management sold 1,564,393 Edwards Lifesciences shares in Q1 2026, an estimated $129M.
  • Edwards Lifesciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2166 holding.
  • Balyasny Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 33 quarters since.
  • Balyasny Asset Management's Edwards Lifesciences position peaked at $154M in Q1 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.